Trial intelligence / Profile preview

HIV Infection and Breastfeeding: Interventions for Maternal and Infant Health

NCT00164736Phase 3Completed

Sponsor
Centers for Disease Control and Prevention
Start
Mar 2004
Primary completion
Jan 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of zidovudine + lamivudine + lopinavir/ritonavir, nevirapine in human immunodeficiency virus infection (HIV), sponsored by Centers for Disease Control and Prevention. Started Mar 2004; status: completed.

02

Drugs

zidovudine + lamivudine + lopinavir/ritonavirnevirapine
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00164736.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00164736.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call